共查询到20条相似文献,搜索用时 15 毫秒
1.
目的:探讨注射器针头划拨法治疗儿童拇指狭窄性腱鞘炎临床疗效,分析病程长短与治疗效果的相关性。方法:纳入2015年4月至2018年10月于我院治疗的拇指狭窄性腱鞘炎患儿59例,根据患儿发病时间分为短程组(发病时间≤6个月,n=28)和长程组(发病时间6个月,n=31),所有患儿采用7#注射器针头划拨法进行治疗,术后1个月及6个月门诊复查并评定临床疗效,观察记录是否残留屈曲挛缩,触发弹响感、主动屈伸拇指指间关节活动度改善情况及术后并发症情况,分析两组患儿病程与治疗效果相关性,记录术后随访结果。结果:短程组治疗有效率为96.43%,长程组治疗有效率为93.55%,两组有效率比较无统计学差异(P0.05)。术后1个月及6个月复查56例患儿均成功解除屈曲挛缩畸形,主动屈伸拇指指间关节活动度改善情况满意,触发激痛点消失,后续随访6~46个月未见复发,未愈的3例患儿经外科手术治疗后达到治愈效果。两组患儿病程长短与治疗效果不存在线性相关性(P0.05)。结论:注射器针头划拨法治疗儿童拇指狭窄性腱鞘炎临床疗效确切,治疗器械普通,创口小,简单易行,在治疗病程大于6个月的儿童拇指狭窄性腱鞘炎也能取得较满意的临床疗效。 相似文献
2.
张磊 《基因组学与应用生物学》2019,38(5):2371-2374
为探讨全肠内营养治疗小儿克罗恩病的临床效果及其护理方法,本研究选取中国医科大学附属盛京医院2014年1月至2016年1月期间收治的60例克罗恩病患儿,采用随机数字表法分为肠内营养治疗的30例患儿(EN组)、肠外营养患儿30例(PN组),对比两种方法的临床疗效差异,并分析实施肠内营养治疗患儿的护理方法。结果表明,治疗前,EN组和PN组患儿的身高、体质量、白蛋白(albumin, ALB)、血红蛋白(hemoglobin, Hb)、前白蛋白、转铁蛋白测定值差异不具有统计学意义(p>0.05);治疗后,EN组患儿的体质量、ALB、Hb、前白蛋白、转铁蛋白测定值均显著地高于PN组(p<0.05);治疗前,EN组和PN组患儿的血沉(erythrocyte sedimentation rate, ESR)、C反应蛋白(C-reactive protein, CRP)及儿童克罗恩病活动指数(pediatric Crohn’s disease activity index, PCDAI)评分差异不具有统计学意义(p>0.05);治疗后,EN组患儿的CRP及PCDAI评分均显著地低于PN组(p<0.05),两组的ESR测定值差异不具有统计学意义(p>0.05)。本研究初步表明,全肠内营养治疗小儿克罗恩病的效果优于肠外营养,在治疗过程中同时应加强护理。 相似文献
3.
目的:分析儿童噬血细胞综合征(hemophagocytic syndrome,HPS)的病因、临床表现、实验室检查结果、治疗和预后特点。方法:回顾性分析我院收治的37例HPS患儿的临床资料。结果:37例HPS患儿(男24例、女13例),年龄2月~9岁,5例(13.5%)有明显家族史,获得性HPS32例(86.5%),包括EB病毒感染16例、巨细胞病毒感染7例,其他原因9例;所有患儿均表现为发热,肝脾肿大,外周血白细胞、血红蛋白、血小板、白蛋白、纤维蛋白原减低,TG、ALT、AST、LDH、铁蛋白升高;5例遗传性HPS患儿死亡4例,放弃治疗1例,剩余32例患儿中好转20例(62.5%),包括痊愈17例,完全缓解后继续治疗中3例,未好转12例(37.5%),其中死亡7例,病情危重放弃治疗3例,复发2例。12例未好转病例中,9例为EBV感染,1例为肾母细胞瘤,1例为幼年类风湿性关节炎合并CMV感染,1例原因不明。遗传性HPS的好转率较继发性HPS明显降低,差异有统计学意义(X2=5.30,P0.05),继发性HPS中EBV感染者的好转率较非EBV感染者低,差异有统计学意义(X2=4.80,P0.05)。结论:及时诊断儿童HPS并明确其病因,对该病的治疗及预后具有重要意义。 相似文献
4.
目的:探讨观察儿童朗格汉斯细胞组织增生症临床治疗方案和效果。方法:选取我院2007年4月-2014年11月收治的儿童朗格汉斯细胞组织细胞增生症65例,按随机数字表法分为观察组(32例)和对照组(33例)。对照组给予朗格汉斯细胞组织细胞增生症-Ⅲ(LCH-Ⅲ)治疗方案,观察组给予难治性2008方案。观察两组患者临床疗效、复发率、并发症、生存率。结果:观察组完全缓解率显著高于对照组(P0.05),而两组患者的复发率和总有效率之间的差异无统计学意义(P0.05);两组治疗后9个月、12个月、24个月生存率差异无统计学意义(P0.05);观察组不良反应发生率为9.38%,对照组为24.24%,观察组稍低于对照组,但两组差异无统计学意义(P0.05)。结论:采用难治性2008方案治疗儿童朗格汉斯细胞组织细胞增生症较LCH-Ⅲ方案疗效更佳,且远期生存率明显改善,还可减少不良反应,值得在临床治疗中推广应用。 相似文献
5.
Santos Lda S Fernandes VC Cruz SG Siqueira WC Goes AM Pedroso ER 《Memórias do Instituto Oswaldo Cruz》2012,107(1):1-10
The levels of total of IgG, IgG1, IgG2, IgG3 and IgG4 were evaluated in 54 patients with chronic paracoccidioidomycosis (PCM) before, during and after treatment using an enzyme-linked immunosorbent assay with Mexo and recombinant Pb27 (rPb27) as the antigens. Mexo was effective in distinguishing PCM patients from individuals in the negative control group (NC) based on total IgG and rPb27 performed worse than Mexo when these two groups were compared. IgG1, IgG2, IgG3 and IgG4 could not be used to clearly distinguish PCM patients from those in the NC group using either antigen. There was no clear relationship between antibody levels and the period of treatment. The majority of patients presented with decreased antibody levels during treatment, with no statistically significant differences among the different periods of treatment. Only IgG4 presented a negative correlation between its levels and clinical improvement during treatment. In total, 65% of untreated PCM patients showed reactivity against IgG4 when the Mexo antigen was used and this reactivity decreased over the course of treatment. There was a tendency towards decreasing antibody levels during treatment, but these antibody levels did not necessarily clear after the treatment was stopped. Mexo was useful for PCM diagnosis using total IgG; however, more studies are necessary before this antigen can be used in measuring the levels of total IgG and its subclasses for monitoring patients during treatment. 相似文献
6.
Thomas Reinehr Kurt Widhalm Dagmar l'Allemand Susanna Wiegand Martin Wabitsch Reinhard W. Holl The APV‐Wiss Study Group German Competence Net Obesity 《Obesity (Silver Spring, Md.)》2009,17(6):1196-1199
Although randomized controlled trials demonstrated the long‐term efficacy of lifestyle interventions in overweight children, the effects of these interventions in clinical practice under real‐life conditions are largely unknown. One hundred twenty‐nine centers specialized in outpatient pediatric obesity care participated in this quality assessment. All patients presenting before the year 2006 for lifestyle intervention of at least 6 months duration in these institutions were analyzed in a 2‐year follow‐up. A total of 21,784 (45% male) overweight children and adolescents aged 2–20 years (mean BMI 30.4 kg/m2, mean SDS‐BMI 2.51, mean age 12.6 years) were included in the analysis. Based on an intention‐to‐treat analysis with variables set back to baseline in lost of follow‐up, 22% of the children reduced their SDS‐BMI after 6 months, 15% after 12 months, and 7% after 24 months, but only in 24, 17, and 8% of children, respectively, complete data were available. In the five treatment centers with the best outcome (518 patients), 83% of the children reduced their overweight after 6 months, 67% after 12 months, and 51% after 24 months. Under real‐life conditions, most treatment centers cannot prove the long‐term efficacy of their interventions due to high drop‐out rate or lack of documentation. Conversely, some institutions achieved a reduction of overweight in nearly the half of their patients 24 months after baseline demonstrating the great heterogeneity in outcome. To improve the effectiveness of lifestyle interventions in real‐life studying, the process and structure quality as well as their long‐term results is urgently needed. 相似文献
7.
目的:探讨低浓度的高渗盐水对重型颅脑损伤患者手术后颅内高压的治疗效果。方法:选取2014年8月至2017年8月本院收治的104例行去骨瓣减压术后出现颅内高压的重型颅脑损伤患者为研究对象,按照随机数表法将其分为实验组、观察组,每组各52例。在持续监测颅内压(ICP)的情况下,实验组、观察组分别给予233.3 m L的3%HS、29.9 m L的23.4%HS,比较两组治疗前后的ICP、平均动脉压(MAP)、中心静脉压(CVP)、血钠(Na+)、钾(K+)、渗透压、肌酐(Cr)、尿素氮(BUN)水平的变化及半年的预后情况。结果:两组治疗后30 min时ICP显著低于治疗前,而MAP明显高于治疗前(P 0.05);实验组治疗后240 min、300 min时ICP显著低于观察组,120 min、240 min、300 min、360 min时MAP均显著高于观察组(P 0.05);两组治疗前后的CVP比较差异无统计学意义(P0.05)。两组治疗后3 d、6 d血Na+均显著高于治疗前,治疗后1 d、3 d、6 d的渗透压均显著高于治疗前(P 0.05),两组治疗前后的血K+、Cr、BUN比较差异无统计学意义(P0.05);两组治疗前后的同期各血生化指标比较差异无统计学意义(P0.05)。实验组治疗半年后死亡6例(11.5%),预后不良14例(26.9%),预后良好32例(61.5%),观察组死亡8例(15.4%),预后不良20例(38.5%),预后良好24例(46.2%),两组比较差异无统计学意义(P0.05)。结论:3%和23.4%两种浓度的HS均能安全迅速降低重型颅脑损伤患者的ICP,且均有明显的扩容效果,但低浓度HS作用持续时间更长。 相似文献
8.
目的:对比分析药物干预和手术切除治疗儿童阻塞性睡眠呼吸暂停低通气综合征(OSAHS)的临床疗效。方法:应用随机数字表法将2015年2月至2017年11月经本院确诊的100例OSAHS患儿分为药物组、手术组,每组50例。药物组采用孟鲁司特钠治疗6个月,手术组行腺样体和扁桃体切除术。6个月后比较两组患儿多导睡眠图监(PSG)的监测结果和生活质量情况,比较两组疗效评定情况,记录手术组无效及并发症的原因。结果:6个月后,药物组、手术组患儿呼吸暂停低通气指数(AHI)、阻塞性呼吸暂停指数(OAI)、微觉醒指数(MAI)和睡眠呼吸紊乱指数(RDI)较治疗前降低,且手术组患儿AHI低于药物(P0.05)。手术组患儿6个月后睡眠障碍、对监护人的影响、身体症状评分较治疗前降低,且低于药物组(P0.05),而药物组治疗前后OSA-18评分各指标比较差异无统计学意义(P0.05)。手术组患儿总有效率为90.00%(45/50),高于药物组的50.00%(25/50),差异有统计学意义(P0.05)。手术组患儿有出血现象的4例、伴舌后坠2例、上呼吸反复道感染6例和鼻炎5例,无效的5例患儿为伴有肥胖的重度OSAHS。结论:对于OSAHS患儿,药物干预和手术切除均可改善患儿PSG指标水平,但手术切除治疗可提高患儿生活质量和治疗有效率。 相似文献
9.
目的:比较分析关节镜下不同术式治疗盘状半月板的临床效果。方法:选取盘状半月板患者85例,其中完全型盘状半月板47例,行完全切除术(A组)23例,行部分切除成形术(B组)24例;不完全性盘状半月板38例,行完全切除术(C组)20例,行部分切除成形术(D组)18例。术后随访观察,膝关节功能评价分别采用国际膝关节文献委员会膝关节评估表(the international knee documentation committee knee evaluation form,IKDC)和Lysholm评分进行。结果:78例患者均得到有效随访。随访时间12-18个月,平均(16.2±3.4)月。术前各组各评分均无显著差异(P0.05)。完全型盘状半月板中,A组术后IKDC和Lysholm评分分别为(92.9±9.7)分、(93.4±8.6)分,优良率为91.3%(21/23),均显著优于B组[(83.5±8.4)分、(82.7±9.2)分、70.8%(17/24)](P0.05)。C组和D组术后各指标比较无显著差异(P0.05)。结论:关节镜下不同术式治疗盘状半月板均可获得较为满意的疗效,但对于完全型盘状半月板而言,采取完全切除术治疗的患者较部分切除成形术者术后疗效具有一定优势。 相似文献
10.
Collaborative Group for Studies of Yellow Fever Vaccine 《Memórias do Instituto Oswaldo Cruz》2015,110(6):771-780
This randomised, double-blind, multicentre study with children nine-23 months old
evaluated the immunogenicity of yellow fever (YF) vaccines prepared with substrains
17DD and 17D-213/77. YF antibodies were tittered before and 30 or more days after
vaccination. Seropositivity and seroconversion were analysed according to the
maternal serological status and the collaborating centre. A total of 1,966 children
were randomised in the municipalities of the states of Mato Grosso do Sul, Minas
Gerais and São Paulo and blood samples were collected from 1,714 mothers.
Seropositivity was observed in 78.6% of mothers and 8.9% of children before
vaccination. After vaccination, seropositivity rates of 81.9% and 83.2%,
seroconversion rates of 84.8% and 85.8% and rates of a four-fold increase over the
pre-vaccination titre of 77.6% and 81.8% were observed in the 17D-213/77 and 17DD
subgroups, respectively. There was no association with maternal immunity. Among
children aged 12 months or older, the seroconversion rates of 69% were associated
with concomitant vaccination against measles, mumps and rubella. The data were not
conclusive regarding the interference of maternal immunity in the immune response to
the YF vaccine, but they suggest interference from other vaccines. The
failures in seroconversion after vaccination support the
recommendation of a booster dose in children within 10 years of the first dose. 相似文献
11.
目的:探讨自拟益气活血方治疗小儿脾肾气虚型肾病综合征的临床疗效。方法:选择2014年6月到2016年10月我院收治的80例脾肾气虚型肾病综合征患儿,按随机数字表法分为对照组和治疗组各40例。对照组给予强的松治疗,治疗组在对照组治疗的基础上给予自拟益气活血方治疗,两组均治疗4个月。评估两组临床疗效,检测治疗前后两组24h尿蛋白、总胆固醇(TC)、血浆白蛋白(Alb)以及肾功能指标包括尿素氮(BUN)、血肌酐(Scr)、血肌酐清除率(Ccr)。结果:治疗组的总有效率为95.00%,明显高于对照组的67.50%,差异具有统计学意义(P0.05)。治疗后,两组24 h尿蛋白、TC、BUN及Scr水平低于治疗前,Alb、Ccr水平高于治疗前,且治疗组上述各指标水平变化均显著优于对照组,差异均具有统计学意义(P0.05)。结论:自拟益气活血方治疗小儿脾肾气虚型肾病综合征的临床疗效显著,能够明显改善患儿肾功能,值得在临床上推广应用。 相似文献
12.
摘要 目的:通过运用Alberta婴幼儿运动量表评估并且治疗脑瘫高危儿,探讨婴幼儿早期运动发育的评价方法。方法:从国际和平妇幼保健院儿保康复科普通门诊2017年12月至2018年12月确诊的脑瘫高危儿中选取24例脑瘫高危患儿,采用随机数字表法随机分为治疗组和对照组,每组12例。治疗组通过量表指导家长进行家庭康复,对照组仅进行康复随访,评估三个月后患儿运动发育的改善情况。结果:治疗三个月后,两组Alberta分值均高于治疗前,且治疗组Alberta分值高于对照组(均P<0.01)。结论:用Alberta婴儿运动量表指导评估、治疗脑瘫高危儿,效果显著,值得临床推广。 相似文献
13.
目的:探讨经皮椎间孔镜下髓核摘除术治疗腰椎间盘突出症(LDH)的临床疗效,分析术后复发的影响因素.方法:选取我院于2017年2月~2019年12月期间收治的LDH患者230例,均给予经皮椎间孔镜下髓核摘除术治疗,观察其疗效、不同时间点视觉疼痛模拟评分量表(VAS)、Oswestry功能障碍指数(ODI)评分及并发症.记... 相似文献
14.
目的:探讨吉西他滨热化疗治疗肝癌的临床效果及对血清O6-甲基鸟嘌呤DNA甲基转移酶(O6-methylguanine-DNA methyltransferase,MGMT)水平的影响。方法:选取2014年2月-2017年4月在我院诊治的59例肝癌患者,根据治疗方法的方法不同分为观察组30例、对照组29例,对照组给予常规化疗,化疗观察3个周期;观察组在对照组化疗的基础上给予吉西他滨热灌注化疗,比较两组的临床疗效、不良反应的发生情况、生存情况及治疗前后血清MGMT表达的变化情况。结果:观察组患者的热灌注化疗均成功进行,治疗前后患者的体温、呼吸频率、心率、血压等对比无显著差异(P0.05)。治疗后,观察组总有效率是66.7%,显著高于对照组(31.0%)(P0.05)。两组治疗期间的毒性反应发生率间无显著差异(P0.05)。两组治疗后血清MGMT表达都较治疗前显著降低(P0.05),且观察组的血清MGMT表达明显比对照组低(P0.05)。随访至2017年11月30日,观察组的疾病进展时间(Time to Progression,TTP)、生存时间(overall survival,OS)分别为8.11±2.19个月和14.29±1.87个月,都显著高于对照组的6.22±1.82个月和11.48±2.19个月(P0.05)。结论:吉西他滨热化疗治疗肝癌可提高疗效,延长患者的生存时间,且不增加毒副反应,可能与其有效降低患者血清MGMT表达有关。 相似文献
15.
OBJECTIVE: Characterizing clinical and biochemical features of children diagnosed with diabetes mellitus between the ages of 6-24 months. DESIGN AND METHODS: Medical records of 42 children diagnosed with diabetes mellitus at age of 6-24 months were reviewed for gender, ethnic origin, family medical history, clinical and biochemical features at onset of diabetes compared with 60 diabetic patients diagnosed at age 5-16 years. RESULTS: Children diagnosed at 6-24 months had at onset more symptoms of apathy, restlessness, hyperglycemia during acute illness and a lower rate of remission than those diagnosed at older age (p < 0.001), significantly more episodes of diabetic ketoacidosis (83% vs. 40%, p < 0.001), lower HbA1c levels (mean 11.6 +/- 3.4 vs. 13.75 +/- 3.4%, p < 0.05) and a higher rate of celiac disease (12% vs. 3%, p = 0.046). There were no significant differences as to other autoimmune diseases. CONCLUSIONS: Patients with diabetes presenting at 6-24 months might be associated with a different clinical pattern and higher rate of celiac disease than diabetes presenting later in life. Understanding the nature and course of diabetes in this age group is crucial for planning interventional and preventive programs. 相似文献
16.
目的:探讨玉屏风颗粒联合西咪替丁对过敏性紫癜患儿临床疗效及外周血免疫学指标的影响。方法:选取2017年1月至2019年12月我院68例过敏性紫癜患儿为研究对象,根据随机化原则将受试儿进行分组,其中对照组34例患儿仅接受西咪替丁治疗,研究组45例患儿在对照组的基础上口服玉屏风颗粒治疗,比较两组的治疗效果、治疗前后外周血免疫学指标水平变化及用药安全性。结果:研究组临床治疗总有效率显著高于对照组(P<0.05),治疗前两组各免疫学指标及各炎性因子水平比较无统计学差异(P>0.05),治疗后两组各免疫学指标及各炎性因子水平较治疗前均明显降低,且研究组显著低于对照组(P<0.05),两组治疗期间不良反应发生率无差异(P>0.05)。结论:玉屏风颗粒联合西咪替丁可有效改善患儿的临床症状及外周血免疫学指标,疗效安全显著,值得在过敏性紫癜患儿治疗中应用及推广。 相似文献
17.
Priscila Marques de Macedo Rodrigo Almeida-Paes Dayvison Francis Saraiva Freitas Fabio Brito-Santos Maria Helena Galdino Figueiredo-Carvalho João Carlos de Almeida Soares Andrea D’Ávila Freitas Rosely Maria Zancopé-Oliveira Antonio Carlos Francesconi do Valle 《Mycopathologia》2017,182(9-10):915-919
Paracoccidioidomycosis (PCM) is a neglected systemic mycosis endemic to Latin America caused by dimorphic fungi of the genus Paracoccidioides. The acute juvenile PCM is a severe type of presentation that usually affects young vulnerable patients and rarely progresses to portal hypertension. Here, two cases of liver disease and portal hypertension as complications of acute juvenile PCM are reported. Diagnosis of PCM was performed by isolation of the fungus and molecular identification of the strains provided through partial sequencing of two protein encoding genes, arf and gp43. Genotypic analysis revealed that Paracoccidioides brasiliensis S1 was the phylogenic species involved in both cases. Patients presented a good clinical response to amphotericin B and sulfamethoxazole–trimethoprim. These results highlight the importance of the interdisciplinary approach in patients with severe forms of PCM to avoid and treat complications, and the necessity of further investigations focusing on host-pathogen interaction in order to explain the broad clinical spectrum in PCM as well as the severity and poor outcome in some clinical cases. 相似文献
18.
目的:探讨孟鲁斯特纳联合玉屏风颗粒治疗小儿过敏性鼻炎患者的临床疗效及安全性。方法:选取于我院进行治疗的小儿过敏性鼻炎患者60例,根据电脑生成的随机数字表将所有患者随机分为实验组与对照组,每组各30例。对照组患者给予孟鲁斯特纳进行治疗,实验组患者在对照组的基础上联合使用中药制剂玉屏风颗粒进行治疗。比较两组患者治疗前后血清免疫球蛋白A(IgA)、免疫球蛋白G(IgG)、免疫球蛋白E(IgE)、白介素6(IL-6)、白介素17(IL-17)及白介素23(IL-23)水平,并对两组患者治疗过程中的不良反应进行记录,评价两组患者的临床疗效。结果:与治疗前相比,两组患者治疗后的血清IgA、IgG水平均升高(P0.05),IgE、IL-6、IL-17及IL-23水平均降低(P0.05);与对照组相比,实验组患者血清IgA、IgG水平及临床总有效率较高(P0.05),IgE、IL-6、IL-17、IL-23水平及不良反应发生率较低(P0.05)。结论:孟鲁斯特纳联合玉屏风颗粒治疗小儿过敏性鼻炎安全有效,可能与其影响机体血清IgA、IgG、IgE、IL-6、IL-17及IL-23水平有关。 相似文献
19.
Seyed Ali Miresmaeili Mazrakhondi Hadi Zare-Zardini 《Reports of Biochemistry & Molecular Biology》2022,11(3):465
Background:Immunological alterations in schizophrenic patients have been considered during last decade. There are no remarkable reports on the changes of IL-17A and IL-21 in schizophrenic patients. Therefore, the purpose of this study was to evaluate changes of serum IL-17A and IL-21 in schizophrenic patients in comparison with healthy controls.Methods:In the present study serum levels of IL-17A and IL-21 in 30 patients with schizophrenia before treatment and three months after treatment were measured by enzyme-linked immunosorbent assay (ELISA) and compare to 30 match healthy control group.Results:Serum levels of IL-21 in schizophrenic patient was significantly higher than control group (P= 0.001). Serum levels of IL-17A in the schizophrenic patients had no significant changes than the control group (P= 0.4). Serum levels of IL-17A in patients with schizophrenia three months after treatment than before treatment had no significant change (P=0.7) and IL-21 serum levels in schizophrenic patient three month after treatment was not significant changed in comparison with this group before treatment (P= 0.06).Conclusion:The serum levels of interlukine-21 is elevated in schizophrenic. Results of this study showed that IL-21 might be involved in the pathologic mechanism of schizophrenia.Key Words: Immunity, Interleukin-17A, Interleukin-21, Schizophrenia 相似文献
20.
目的:探讨经支气管镜氩离子凝固术治疗伴有咯血的晚期中心型肺癌的疗效。方法:选取2011年12月-2013年6月期间我院收治的晚期中心型肺癌咯血的患者60例,将其随机分为观察组(30例)和对照组(30例),观察组给予经支气管镜氩离子凝固术联合全身化疗,对照组给予经支气管镜介入局部用药联合全身化疗,对比两组患者治疗后的临床疗效、24h动脉血气分析、肺功能、止血有效率及治疗后3天、3~7天,7天复发率以及总复发率和不良反应情况。结果:治疗后两组患者的临床症状均得到一定的改善,观察组患者的临床有效率为80.0%(24/30)显著高于对照组的56.7%(17/30),差异具有统计学意义(P0.05);观察组患者在发热、呼吸困难、咳嗽、胸痛及咯血等方面的症状缓解率均显著高于对照组,比较差异均有统计学意义(均P0.05);治疗后观察组肺功能和24h动脉血气分析各项指标均显著优于治疗前,观察组患者的的以上指标均显著优于对照组,差异均有统计学意义(均P0.05);治疗后观察组患者的止血有效率为100%,显著高于对照组的56.7%(17/30),且观察组患者术后3天、3~7天,7天复发率以及总复发率均小于对照组,两组止血有效率和总复发率比较差异均有统计学意义(均P0.05);观察组患者不良反应的发生率为10.0%,对照组为13.3%,两组相比无显著差异(P0.05)。结论:经支气管镜氩离子凝固术联合全身化疗治疗老年晚期中心型肺癌咯血具有较好的临床疗效,止血迅速有效,且复发率低,能够缓解呼吸道阻塞症状,改善呼吸功能,是一种不错的选择,值得在临床普遍推广与应用。 相似文献